Search Login Register

Cysticercosis Summary

Description: Infection with CYSTICERCUS, the larval form of the various tapeworms of the genus Taenia (usually T. solium in man). In humans they penetrate the intestinal wall and invade subcutaneous tissue, brain, eye, muscle, heart, liver, lung, and peritoneum. Brain involvement results in NEUROCYSTICERCOSIS.

Also Known As: Cysticercoses

Networked: 787 relevant articles (61 outcomes, 77 trials/studies) for this Disease

Key Drugs and Agents for Cysticercosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antigens : 20 outcomes 28 studies in 246 results : IBA
  2. Praziquantel (Biltricide) : 19 outcomes 7 studies in 110 results : FDA 1
  3. Albendazole (Albenza) : 11 outcomes 8 studies in 59 results : FDA 1
  4. Antibodies : 5 outcomes 8 studies in 96 results : IBA
  5. DNA (Deoxyribonucleic Acid) : 4 outcomes 4 studies in 17 results : IBA
  6. oxfendazole : 3 outcomes 4 studies in 14 results : IBA
  7. Vaccines : 3 outcomes 2 studies in 23 results : IBA
  8. Steroids : 2 outcomes 2 studies in 11 results : IBA
  9. Complementary DNA (cDNA) : 2 outcomes 2 studies in 8 results : IBA
  10. Anthelmintics : 2 outcomes 2 studies in 4 results : IBA
Show All >>

Diseases Related to Cysticercosis

  1. Infection
  2. Schistosomiasis (Bilharziasis)
  3. Neurocysticercosis
  4. Echinococcosis (Hydatid Cysts)
  5. Parasitic Diseases (Parasitic Disease)
Show All >>

Key Therapies for Cysticercosis

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 1 outcome 3 studies in 18 results
  2. Aftercare (After-Treatment) : 1 outcome 1 study in 13 results
  3. Immunotherapy : 1 outcome in 3 results
  4. Injections : 1 outcome in 1 result
  5. Ventriculoperitoneal Shunt : 1 study in 4 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.